about
Serotonergic signalling suppresses ataxin 3 aggregation and neurotoxicity in animal models of Machado-Joseph disease.Serotonin 5-HT1A receptors as targets for agents to treat psychiatric disorders: rationale and current status of research.Topsy turvy: functions of climbing and mossy fibers in the vestibulo-cerebellum.The effect of piracetam on ataxia: clinical observations in a group of autosomal dominant cerebellar ataxia patients.Therapeutic targets and investigated treatments for Ataxia-Telangiectasia
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Treatment of cerebellar ataxia with 5-HT1A agonist.
@ast
Treatment of cerebellar ataxia with 5-HT1A agonist.
@en
type
label
Treatment of cerebellar ataxia with 5-HT1A agonist.
@ast
Treatment of cerebellar ataxia with 5-HT1A agonist.
@en
prefLabel
Treatment of cerebellar ataxia with 5-HT1A agonist.
@ast
Treatment of cerebellar ataxia with 5-HT1A agonist.
@en
P2093
P1433
P1476
Treatment of cerebellar ataxia with 5-HT1A agonist.
@en
P2093
Asako Takei
Hidenao Sasaki
Ichiro Yabe
Takeshi Hamada
P2860
P2888
P304
P356
10.1080/14734220500222318
P577
2005-01-01T00:00:00Z
P6179
1044750825